Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — December 2025

Biotek-snakken — December 2025

Planlagt Fastgjort Låst Flyttet Biotek-snakken
80 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #14

    PILA PHARMA ANNOUNCES PRE-CLINICAL OBESITY AND AMYLIN
    SPECIALIST PROFESSOR THOMAS LUTZ TO JOIN AS SCIENTIFIC
    ADVISER https://cdn.bequoted.com/media/1/ea30b14e-f4ed-474a-b0f7-f27f3cc5d379/PILA_PHARMA_Pressrelease_2025-12-04.pdf

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #15

      Godmorgen...

      1 Reply Last reply
      0
      • L Offline
        L Offline
        LP90
        wrote on sidst redigeret af
        #16

        Pila også en jeg har en pæn stak i 🙂

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #17

          Dårligt nyt fra Cantargia. https://cantargia.com/en/press-releases/cantargia-provides-update-on-overall-survival-data-from-trifour

          1 Reply Last reply
          0
          • L Offline
            L Offline
            LP90
            wrote on sidst redigeret af
            #18

            ja tro det eller ej Cantargia har jeg også i 3 depoter og også for mange solgte dog 30.000 stk. i tirsdag så det var godt nok har suppleret lidt i dag på 3,47 🙂

            1 Reply Last reply
            0
            • F Offline
              F Offline
              Fandel
              wrote on sidst redigeret af
              #19

              Godmorgen...

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #20

                Godmorgen 🙂

                1 Reply Last reply
                0
                • F Offline
                  F Offline
                  Fandel
                  wrote on sidst redigeret af
                  #21

                  Godmorgen...

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #22

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • F Offline
                      F Offline
                      Fandel
                      wrote on sidst redigeret af
                      #23

                      Godmorgen...

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #24

                        PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD

                        Link Preview Image
                        PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD | Placera.se

                        PARETO SER FÖRSTÄRKT FÖRHOPPNING BI-1808 NÅR MARKNAD

                        favicon

                        placera.se (www.placera.se)

                        "Pareto upprepar sin köprekommendation för Bioinvent med en riktkurs på 134 kronor."

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #25

                          BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025

                          Link Preview Image
                          BioInvent to Present Updated Phase 2a BI-1808 Monotherapy Data in CTCL at ASH 2025

                          favicon

                          BioInvent (www.bioinvent.com)

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Sukkeralf
                            wrote on sidst redigeret af
                            #26

                            Kymera præsenterer deres vigtige og ventede fase Ib data i dag for deres STAT6 degrader.

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #27

                              Link Preview Image
                              Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December 8, 2025

                              Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025 WATERTOWN, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, will announce results from the BroADen Phase 1b clinical trial evaluating KT-621, its oral STAT6 degrader, in patients with moderate to severe atopic dermatitis (AD) on Monday,

                              favicon

                              Yahoo Finance (finance.yahoo.com)

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #28

                                Nurix præsenterede i weekenden data på ASH vedrørende deres BTK degrader.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #29

                                  Monte Rosa Therapeutics vil præsentere fase 1/2 data på deres GPST1 molecular glue degrader MRT-2359 senere i år, men den er jeg lidt nervøs omkring. Synes flere af selskaber glider væk fra cancer og MRT virker ej heller super begejstret.

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Sukkeralf
                                    wrote on sidst redigeret af
                                    #30

                                    Dog rart med data på diverse degraders så vi stille og roligt for vished om hvor lovende denne nye modalitet er.

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      Mads83
                                      wrote on sidst redigeret af
                                      #31

                                      LP90 / Darvin (o.a): Curasight, fra Q3 rapporten 27. Nov.: To support and accelerate the strategic business
                                      development, discussions are currently ongoing with a number of major pharma companies with a view to uncover opportunities and interest in uTRACE® and uTREAT®.

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        Mads83
                                        wrote on sidst redigeret af
                                        #32

                                        Kunne man forvente en ny partneraftale 1-2 måneder efter data fra FPD, der forventes denne uge (eller inden årets ud
                                        løb)?

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #33

                                          Kymera leverer meget stærke data er min umiddelbare vurdering - webcast om ikke så lang tid:

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper